Cost utility analysis of long-term telemonitoring of patients with DMT2: Results of the Greek pilot of the renewing health multicenter pragmatic randomized trial

• George E. Dafoulas,
• Afentoula Mavrodi,
• Alexandra Bargiota,
• Haralambos Giannakakos,
• Panagiotis Stafylas,
• Paraskevi Gkiata,
• Petros Pechlivangolou,
• Kyriaki Theodorou,
• Georgios Koukoulis,
• Vasilios Aletras

Affiliations

George E. Dafoulas

Faculty of Medicine, University of Thessaly, Greece

Afentoula Mavrodi

Department of Business Administration, University of Macedonia, Thessaloniki, Greece

Alexandra Bargiota

Department of Endocrinology and Metabolic Diseases, Regional University Hospital of Larisa, Larisa, Greece

Haralambos Giannakakos

Regional University Hospital, 5th Regional Health Authority of Thessaly and Sterea, Larisa, Greece

Panagiotis Stafylas

Health Information Management SA, Bruxelles, Belgium

Paraskevi Gkiata

Telehealth Center, Intermunicipal Digital Community of Central Greece, Trikala, Greece

Petros Pechlivangolou

Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Canada

Kyriaki Theodorou

Faculty of Medicine, University of Thessaly, Greece

Georgios Koukoulis

Department of Endocrinology and Metabolic Diseases, Regional University Hospital of Larisa, Larisa, Greece

Vasilios Aletras

Department of Business Administration, University of Macedonia, Thessaloniki, Greece